TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 18TH EDITION BY WILLIHNGANZ | COMPLETE STUDY GUIDE.

TEST BANK FOR
CLAYTON‟S BASIC
PHARMACOLOGYFOR
NURSES 18THEDITION BY
WILLIHNGANZ

,Chapter 1: Drug Definitions, Standards, and Information
bg bg bg bg bg bg




SourcesTest Bank
bg b
g bg




MULTIPLE CHOICE bg




1. What is the name under which a drug is listed by the U.S. Food and Drug
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




bg Administration(FDA)? g
b




a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C b g




The official name is the name under which a drug is listed by the FDA. The brand name,
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




or trademark, is the name given to a drug by its manufacturer. The nonproprietary, or
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




generic,name is provided by the U.S. Adopted Names Council.
bg g
b bg bg bg bg bg bg bg bg




DIF: Cognitive Level: Knowledge REF: p. 1 OBJ: bg bg bg bg bg bg




2TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
b g bg bg bg bg bg bg bg




2. Which source contains information specific to nutritional supplements?
bg bg bg bg bg bg bg




a. USP Dictionary of USAN & International Drug Names bg bg bg bg bg bg bg




b. Natural Medicines Comprehensive Database bg bg bg




c. United States Pharmacopoeia/National Formulary (USP NF) bg bg bg bg bg




d. Drug Interaction Facts bg bg




ANS: C b g




United States Pharmacopoeia/National Formulary contains information specific to
bg bg bg bg bg bg bg




nutritionalsupplements. USP Dictionary of USAN & International Drug Names is a
bg g
b bg bg bg bg bg bg bg bg bg bg




compilation of drug names, pronunciation guide, and possible future FDA approved drugs; it
bg bg bg bg bg bg bg bg bg bg bg bg bg




does not include nutritional supplements. Natural Medicines Comprehensive Database
bg bg bg bg bg bg bg bg bg




contains evidence basedinformation on herbal medicines and herbal combination products; it
bg bg bg g
b bg bg bg bg bg bg bg bg




does not include information specific to nutritional supplements. Drug Interaction Facts
bg bg bg bg bg bg bg bg bg bg bg




contains comprehensive information on drug interaction facts; it does not include nutritional
bg bg bg bg bg bg bg bg bg bg bg bg




supplements.
bg




DIF: Cognitive Level: Knowledge REF: p. 2 bg bg bg bg bg bg OBJ:
4TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Physiological Integrity
b g bg bg bg bg bg




3. What is the most comprehensive reference available to research a drug interaction?
bg bg bg bg bg bg bg bg bg bg bg




a. Drug Facts and Comparisons bg bg bg




b. Drug Interaction Facts bg bg




c. Handbook on Injectable Drugs bg bg bg




d. Martindale—The Complete Drug Reference bg bg bg




ANS: B b g

, First published in 1983, Drug Interaction Facts is the most comprehensive book available
bg bg bg bg bg bg bg bg bg bg bg bg




ondrug interactions. In addition to monographs listing various aspects of drug interactions,
bg bg bg bg bg bg bg bg bg bg bg bg bg




this information is reviewed and updated by an internationally renowned group of physicians
bg bg bg bg bg bg bg bg bg bg bg bg bg




andpharmacists with clinical and scientific expertise.
bg bg bg bg bg bg bg




DIF: Cognitive Level: Comprehension REF: p. 3 bg bg bg bg bg bg OBJ:
3TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Physiological Integrity
b g bg bg bg bg bg




4. The physician has written an order for a drug with which the nurse is unfamiliar. Which
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




section of the Physicians’ Desk Reference (PDR) is most helpful to get information about
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




thisdrug?
bg bg




a. Manufacturer‟s section bg




b. Brand and Generic Name section bg bg bg bg




c. Product Category section bg bg




d. Product Information section bg bg




ANS: B b g




A physician‟s order would include the brand and/or generic name of the drug. The
bg bg bg bg bg bg bg bg bg bg bg bg bg




alphabeticindex in the PDR would make this section the most user friendly. Based on a
bg g
b bg bg bg bg bg bg bg bg bg bg bg bg bg bg




physician‟s order, manufacturer‟s information and classification information would not be
bg bg bg bg bg bg bg bg bg bg




known. The Manufacturer‟s section is a roster of manufacturers. The Product Category
bg bg bg bg bg bg bg bg bg bg bg bg




section lists products subdivided by therapeutic classes, such as analgesics, laxatives,
bg bg bg bg bg bg bg bg bg bg bg




oxytocics, and antibiotics. The Product Information section contains reprints of the package
bg bg bg bg bg bg bg bg bg bg bg bg




inserts for the major products of manufacturers.
bg bg bg bg bg bg bg




DIF: Cognitive Level: Comprehension REF: p. 3 bg bg bg bg bg bg OBJ:
4TOP: Nursing Process Step: Planning
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Physiological Integrity
b g bg bg bg bg bg




5. Which online drug reference makes available to health care providers and the public a
bg bg bg bg bg bg bg bg bg bg bg bg bg




bg standard, comprehensive, up to date look up and downloadable resource about medicines?
bg bg bg bg bg bg bg bg bg bg bg




a. American Drug Index bg bg




b. American Hospital Formulary bg bg




c. DailyMed
d. Physicians’ Desk Reference (PDR) bg bg bg




ANS: C b g




DailyMed makes available to health care providers and the public a standard,
bg bg bg bg bg bg bg bg bg bg bg




comprehensive,up to date look up and downloadable resource about medicines. The American
bg g
b bg bg bg bg bg bg bg bg bg bg bg




Drug Index is not appropriate for patient use. The American Hospital Formulary is not
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




appropriate for patient use. The PDR is not appropriate for patient use.
bg bg bg bg bg bg bg bg bg bg bg bg




DIF: Cognitive Level: Knowledge REF: p. 4 bg bg bg bg bg bg OBJ:
5TOP: Nursing Process Step: Implementation
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Physiological Integrity
b g bg bg bg bg bg




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




a. Federal Food, Drug, and Cosmetic Act (1938) bg bg bg bg bg bg




b. Durham Humphrey Amendment (1952) bg bg bg




c. Controlled Substances Act (1970) bg bg bg




This study source was downloaded by 100000761823232 from CourseHero.com on 04-12-2021 14:25:43 GMT -05:00
bg bg bg bg bg bg bg bg bg bg bg bg bg




https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/

, d. Kefauver Harris Drug Amendment (1962) bg bg bg bg




ANS: A b g




The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




of all drugs before marketing. Later amendments and acts helped tighten FDA control and
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




be used safely without medical supervision and restricts their sale to prescription by a licensed
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




practitioner. The Controlled Substances Act addresses only controlled substances andtheir
bg bg bg bg bg bg bg bg bg bg bg




categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greaterdrug
bg bg bg bg bg bg bg bg bg bg bg bg




safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




before marketing them.
bg bg bg




DIF: Cognitive Level: Knowledge REF: p. 4 bg bg bg bg bg bg OBJ:
8TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Physiological Integrity
b g bg bg bg bg bg




7. Meperidine (Demerol) is a narcotic with a high potential for physical and bg bg bg bg bg bg bg bg bg bg bg




bg psychologicaldependency. Under which classification does this drug fall? g
b bg bg bg bg bg bg bg




a. I
b. II
c. III
d. IV
ANS: B b g




Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




severe psychological and physical dependence. Schedule I drugs have high potential for
bg bg bg bg bg bg bg bg bg bg bg bg




abuseand no recognized medical use. Schedule III drugs have some potential for abuse. Use
bg g
b bg bg bg bg bg bg bg bg bg bg bg bg bg




may lead to low to moderate physical dependence or high psychological dependence. Schedule
bg bg bg bg bg bg bg bg bg bg bg bg bg




IV drugs have low potential for abuse. Use may lead to limited physical or psychological
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




dependence.
bg




DIF: Cognitive Level: Comprehension REF: p. 4 | p. 5 OBJ: bg bg bg bg bg bg bg bg bg




7TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
b g bg bg bg bg bg bg bg




8. What would the FDA do to expedite drug development and approval for an outbreak
bg bg bg bg bg bg bg bg bg bg bg bg bg




ofsmallpox, for which there is no known treatment?
bg bg bg bg bg bg bg bg bg




a. List smallpox as a health orphan disease. bg bg bg bg bg bg




b. Omit the preclinical research phase. bg bg bg bg




c. Extend the clinical research phase. bg bg bg bg




d. Fast track the investigational drug. bg bg bg bg




ANS: D b g




Once the Investigational New Drug Application has been approved, the drug can receive
bg bg bg bg bg bg bg bg bg bg bg bg




highest priority within the agency, which is called fast tracking. A smallpox outbreak would
bg bg bg bg bg bg bg bg bg bg bg bg bg bg




become a priority concern in the world. Orphan diseases are not researched in a priority
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




manner. Preclinical research is not omitted. Extending any phase of the research would mean a
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




longer time to develop a vaccine. The FDA must ensure that all phases of the preclinical
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




andclinical research phase have been completed in a safe manner.
bg bg bg bg bg bg bg bg bg bg bg




DIF: Cognitive Level: Knowledge REF: p. 7 bg bg bg bg bg bg OBJ:
8TOP: Nursing Process Step: Assessment
bg bg b g bg bg bg




This study source was downloaded by 100000761823232 from CourseHero.com on 04-12-2021 14:25:43 GMT -05:00
bg bg bg bg bg bg bg bg bg bg bg bg bg




https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/